GRCENasdaq

Grace Therapeutics, Inc.

Alert me on GRCE

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 22 Buy Opaleye Management Inc. Insider

1 week

Result in4 trading days

1 month

Result in20 trading days

3 months

Result in62 trading days

6 months

Result in125 trading days

Oct 17 Buy Opaleye Management Inc. Insider

1 week

Result in1 trading day

1 month

Result in17 trading days

3 months

Result in59 trading days

6 months

Result in122 trading days

Oct 14 Buy Opaleye Management Inc. Insider

1 week

+4.2%S&P +0.5%

1 month

Result in14 trading days

3 months

Result in56 trading days

6 months

Result in119 trading days

Oct 6 Buy Opaleye Management Inc. Insider

1 week

−3.6%S&P −0.1%

1 month

Result in8 trading days

3 months

Result in50 trading days

6 months

Result in113 trading days

Oct 2 Buy Opaleye Management Inc. Insider

1 week

+0.5%S&P +1.2%

1 month

Result in6 trading days

3 months

Result in48 trading days

6 months

Result in111 trading days

Show all 9

Oct 2 Buy Opaleye Management Inc. Insider

1 week

+0.5%S&P +1.2%

1 month

Result in6 trading days

3 months

Result in48 trading days

6 months

Result in111 trading days

Sep 11 Buy Opaleye Management Inc. Insider

1 week

−5.0%S&P −0.1%

1 month

−9.0%S&P +2.1%

3 months

Result in33 trading days

6 months

Result in96 trading days

Sep 10 Buy Kohli Prashant Insider

1 week

−5.8%S&P +0.6%

1 month

−8.0%S&P +3.0%

3 months

Result in32 trading days

6 months

Result in95 trading days

Aug 19 Buy Opaleye Management Inc. Insider

1 week

−2.3%S&P −0.4%

1 month

−4.1%S&P −0.7%

3 months

Result in17 trading days

6 months

Result in80 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for GRCE

31 held · newest 531 held · newest 2

Loading the filings.

See all 31 filings for GRCE

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

Oct 17 Insider

Opaleye Management Inc. (10% owner) bought $290K

Result in 1 trading day

Result in 17 trading days

Result in 59 trading days

Result in 122 trading days

Oct 5 Insider

Opaleye Management Inc. (10% owner) bought $172K

A week later−3.6%S&P −0.1%

Result in 8 trading days

Result in 50 trading days

Result in 113 trading days

Sep 10 Insider

2 insiders bought within 1 day, $246K in total

A week later−5.0%S&P −0.1%

A month later−9.0%S&P +2.1%

Result in 33 trading days

Result in 96 trading days

Stakes

Jun 30, 2026 Schedule 13G, amended

ADAR1 Capital Management, LLC: 9.9%, 1,806,216 shares

Jun 30, 2026 Schedule 13G, amended

Nantahala Capital Management, LLC: 6.8%, 1,178,203 shares

Aug 5, 2026 Schedule 13G

Opaleye Management Inc.: 13.1%, 2,748,392 shares

Mar 31, 2026 Schedule 13G, amended

ADAR1 Capital Management, LLC: 9.9%, 1,717,009 shares

Mar 31, 2026 Schedule 13G, amended

Orin Hirschman: 4.9%, 814,000 shares

Dec 31, 2025 Schedule 13G, amended

ADAR1 Capital Management, LLC: 9.9%, 1,646,173 shares

Dec 31, 2025 Schedule 13G, amended

Nantahala Capital Management, LLC: 10%, 1,586,659 shares

Dec 31, 2025 Schedule 13G, amended

Orin Hirschman: 5.9%, 907,217 shares

Sep 30, 2025 Schedule 13G, amended

ADAR1 Capital Management, LLC: 9.9%, 1,529,200 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.